30
Views
6
CrossRef citations to date
0
Altmetric
Review

Hypothalamic-pituitary magnetic resonance imaging in growth hormone deficiency

, , , , &
Pages 413-423 | Published online: 10 Jan 2014

References

  • Tortori-Donati P, Rossi A, Biancheri R. Sellar and suprasellar disorders. In: Pediatric Neuroradiology. Tortori-Donati P (Ed.). Springer, Berlin, Germany, 855–891 (2005).
  • Maghnie M, Ghirardello S, Genovese E. Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. J. Endocrinol. Invest.27(5), 496–509 (2004).
  • Argyropoulou MI, Xydis V, Kiortsis DN et al. Pituitary gland signal in pre-term infants during the first year of life: an MRI study. Neuroradiology46(12), 1031–1035 (2004).
  • Miki Y, Kataoka ML, Shibata T et al. The pituitary gland: changes on MR images during the 1st year after delivery. Radiology235(3), 999–1004 (2005).
  • Maghnie M, Villa A, Aricò M et al. Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. J. Clin. Endocrinol. Metab.74(4), 795–800 (1992).
  • Maghnie M, Cosi G, Genovese E et al. Central diabetes insipidus in children and young adults. N. Engl. J. Med.343(14), 998–1007 (2000).
  • Moses AM, Calyton B, Hochhauser L. Use of T1-weighted MR imaging to differentiate between primary polydipsia and central diabetes insipidus. Am. J. Neuroradiol.13(5), 1273–1277 (1992).
  • Fink AM, Vidmar S, Kumbla S et al. Age-related pituitary volumes in prepubertal children with normal endocrine function: volumetric magnetic resonance data. J. Clin. Endocrinol. Metab.90(6), 3274–3278 (2005).
  • Takano K, Utsunomiya H, Ono H, Ohfu M, Okazaki M. Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. Am. J. Neuroradiol.20(2), 312–315 (1999).
  • Marziali S, Gaudiello F, Bozzao A et al. Evaluation of anterior pituitary gland volume in childhood using three-dimensional MRI. Pediatr. Radiol.34(7), 547–551 (2004).
  • Maghnie M, Triulzi F, Larizza D et al. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J. Clin. Endocrinol. Metab.73(1), 79–83 (1991).
  • Abrahams JJ, Trefelner E, Boulware SD. Idiopathic growth hormone deficiency: MR findings in 35 patients. Am. J. Neuradiol.12(1), 155–160 (1991).
  • Cacciari E, Zucchini S, Carlà G et al. Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance. Arch. Dis. Child.65(11), 1199–1202 (1990).
  • Argyropoulou M, Perignon F, Brauner R, Brunelle F. Magnetic resonance imaging in the diagnosis of growth hormone deficiency. J. Pediatr.120(6), 886–891 (1992).
  • Cacciari E, Zucchini S, Ambrosetto P et al. Empty sella in children and adolescents with possible hypothalmic-pituitary disorders. J. Clin. Enocrinol. Metab.78(3), 767–771 (1994).
  • Triulzi F, Scotti G, di Natale B et al. Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics93(3), 409–416 (1993).
  • Nagel BH, Palmbach M, Petersen D, Ranke MB. Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion. Eur.J. Pediatr.156(10), 758–763 (1997).
  • Chen S, Léger J, Garel C, Hassan M, Czernichow P. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J. Clin. Endocrinol. Metab.84(7), 2408–2413 (1999).
  • Vannelli S, Avataneo T, Benso L et al. Magnetic resonance and the diagnosis of short stature of hypothalamic–hypophyseal origin. Acta Pediatr.82(2), 155–161 (1993).
  • Zucchini S, di Natale B, Ambrosetto P et al. Role of magnetic resonance imaging in hypothalamic–pituitary disorders. Horm. Res.44(Suppl. 3), 8–14 (1995).
  • Pinto G, Netchine I, Sobrier ML, Brunelle F, Souberbielle JC, Brauner R. Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. J. Clin. Endocrinol. Metab.82(10), 3450–3454 (1997).
  • Maghnie M, Loche S, Cappa M. Pituitary magnetic resonance imaging in idiopathic and genetic growth hormone deficiency. J. Clin. Endocrinol. Metab.88(4), 1911–1912 (2003).
  • Dupuis-Girod S, Gluckman E, Souberbielle JC, Brauner R. Growth hormone deficiency caused by pituitary stalk interruption in Fanconi’s anemia. J. Pediatr.138(1), 129–133 (2001).
  • Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr. Rev.23(4), 431–442 (2002).
  • Dattani MT. Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin. Endocrinol. (Oxford)63(2), 121–130 (2005).
  • Netchine I, Sobrier ML, Krude H et al. Mutations in Lhx3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genet.25(2), 182–186 (2000).
  • Machinis K, Pantel J, Netchine I et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox. Am. J. Hum. Genet.69(5), 961–968 (2001).
  • Roessler E, Du YZ, Mullor JL et al. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc. Natl Acad. Sci. USA100(23), 13424–1349 (2003).
  • Woods KS, Cundall M, Turton J et al. Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am. J. Hum. Genet.76(5), 833–849 (2005).
  • Mullis PE. Genetic control of growth. Eur. J. Endocrinol.52(1), 11–31 (2005).
  • Philips JA III. Inherited defects in growth hormone synthesis and action. In: The Metabolic and Molecular Basis of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA, 3023–3044 (1995).
  • Rosenfeld RG, Cohen P. Disorders of growth hormone/insulin-like growth factor secretion and action. In: Pediatric Endocrinology.Mark Sperling (Ed.). Saunders, PA, USA, 211–288 (2002).
  • Osorio MGF, Marui S, Jorge AAL et al. Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or Prop-1 genes. J. Clin. Endocrinol. Metab.87(11), 5076–5084 (2002).
  • Binder G, Nagel BH, Ranke MB, Mullis PE. Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin. Eur. J. Endocrinol.147(6), 755–60 (2002).
  • Besson A, Salemi S, Deladoey J et al. Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J. Clin. Endocrinol. Metab.90(5), 2493–2499 (2005).
  • Salemi S, Yousefi S, Baltensperger K et al. Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion. Eur. J. Endocrinol.153(6), 791–802 (2005).
  • Nijenhuis M, van den Akker EL, Zalm R et al. Familial neurohypophysial diabetes insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone. J. Clin. Endocrinol. Metab.86(7), 3410–3420 (2001).
  • Murray RA, Maheshwari HG, Russel EJ, Baumann G. Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. Am. J. Neuroradiol.21(4), 685–689 (2000).
  • Oliveira HA, Salvatori R, Krauss MP, Oliveira CR, Silva PR, Aguiar-Oliveira MH. Magnetic resonance imaging study of pituitari morphology in subjects homozygous for a null mutation of the growth hormone releasing hormone receptor gene. Eur. J. Endocrinol.148(4), 427–432 (2003).
  • Frohman LA, Kineman RD. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol. Metab.137(7), 299–303 (2002).
  • Kornreich L, Horev G, Schwarz M, Karmazyn B, Laron Z. Pituitary size in patients with Laron syndrome (primary GH insensitivity). Eur. J. Endocrinol.148(3), 339–341 (2003).
  • Tatsumi K, Miyai K, Notomi T et al. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nature Genet.1(1), 56–58 (1992).
  • Cogan JD, Wu W, Phillips JA III et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab.83(9), 3346–3349 (1998).
  • Arroyo A, Pernasetti F, Vasilyev VV, Amato P, Yen SSC, Mellon PL. A unique case of combined pituitary hormone deficiency caused by a Prop-1 gene mutation (R120C) associated with normal height and absent puberty. Clin. Endocrinol. (Oxford)57(2), 283–291 (2002).
  • Vieira TC, da Silva DMR, Cerutti JM et al. Familial combined pituitary hormone deficiency due to a novel mutation R99Q in the hot spot region of prophet of Pit-1 presenting as constitutional growth delay. J. Clin. Endocrinol. Metab.88(1), 38–44 (2003).
  • Bottner A, Keller E, Kratzsch J et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J. Clin. Endocrinol. Metab.89(10), 5256–5265 (2004).
  • Pfäffle R, Blankenstein O, Wüller S, Heimann K, Heimann G. Pituitary transcription factors, POU1F1 and Prop-1 defects. In: Hypothalamic-Pituitary Development. Rappaport R, Amselem S (Eds). Karger, Basel, Switzerland 61–67 (2001).
  • Fofanova O, Takamura N, Kinoshita EI et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with Prop-1 mutations. Am. J. Roentgenol.174(2), 555–559 (2000).
  • Riepe FG, Partsch CJ, Blankenstein O, Mönig H, Pfäffle RW, Sippell WG. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to Prop-1 mutation. J. Clin. Endocrinol. Metab.86(9), 4353–4357 (2001).
  • Teinturier C, Vallette S, Adamsbaum C, Bendaoud M, Brue T, Bougnères PF. Pseutumor of the pituitary due to Prop-1 deletion. J. Ped. Endocrinol. Metab.15(1), 95–101 (2002).
  • Vallette-Kasic S, Barlier A, Teinturier C et al. Prop-1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J. Clin. Endocrinol. Metab.86(9), 4529–4535 (2001).
  • Turton JP, Mehta A, Raza J et al. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clin. Endocrinol. (Oxford)63(1), 10–18 (2005).
  • Voutetakis A, Argyropoulou M, Sertedaki A et al. Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J. Clin. Endocrinol. Metab.89(5), 2200–2206 (2004).
  • Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA. Role of PROP1 in pituitary gland growth. Mol. Endocrinol.19(3), 698–710 (2005).
  • Dattani MT, Robinson IC. Hesx1 and septo-optic dysplasia. Rev. Endocrinol. Metab. Disord.3(4), 289–300 (2002).
  • Carvalho LR, Woods KS, Mendonca BB et al. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor–corepressor interaction. J. Clin. Invest.112(8), 1192–1201 (2003).
  • Cohen RN, Cohen LE, Botero D et al. Enhanced repression by HESX1 as a cause of hypopituitarism and septo-optic dysplasia. J. Clin. Endocrinol. Metab.88(10), 4832–4839 (2003).
  • Brickman JM, Clements M, Tyrell R et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development128(24), 5189–5199 (2001).
  • Thomas PQ, Dattani MT, Brickman JM et al. Heterozygous Hesx1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum. Mol. Genet.10(1), 39–45 (2001).
  • Sobrier ML, Netchine I, Heinrichs C et al. Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Hum. Mutat.25(5), 503–511 (2005).
  • Sobrier ML, Maghnie M, Vié-Luton MP, Secco A, Di Iorgi N, Amselem S. Novel HESX1 mutations are associated with life-threatening neonatal phenotype, anterior pituitary aplasia, normally located posterior pituitary and developmental defects in the absence of optic nerve abnormalities. Proc. Eur. Soc. Pediatr. Endocrinol. Lyon, France, P2751 (2005).
  • Sobrier ML, Attie-Bitach T, Netchine I, Encha-Razavi F, Vekemans M, Amselem S. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expr. Patterns5(2), 279–284 (2004).
  • Palme C, Bellone F, Schonau E et al. Frequency and phenotype of panhypopituitarism due to LHX-3 gene defects. Proc. Eur. Soc. Pediatr. Endocrinol. Ljubljana, Slovenia, P1137 (2003).
  • Sloop KW, Walvoord EC, Showalter AD, Pescovitz OH, Rhodes SJ. Molecular analysis of Lhx3 and Prop-1 in pituitary hormone deficiency patients with posterior pituitary ectopia. J. Clin. Endocrinol. Metab.85(8), 2701–2708 (2000).
  • Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, Lovell-Badge R. SOX3 is required during the formation of the hypothalamo-pituitary axis. Nature Genet.36(3), 247–255 (2004).
  • Laumonnier F, Ronce N, Hamel BC et al. Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am. J. Hum. Genet.71(6), 1450–1455 (2002).
  • Solomon NM, Nouri S, Warne GL, Lagerstrom-Fermer M, Forrest SM, Thomas PQ. Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics79(4), 553–559 (2002).
  • Maghnie M, Aimaretti G, Bellone S et al. Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur. J. Endocrinol.152(4), 589–596 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.